Montana 2025 Regular Session

Montana Senate Bill SB503

Introduced
2/25/25  
Refer
2/26/25  
Engrossed
3/7/25  
Refer
3/17/25  
Enrolled
4/11/25  

Caption

Allow use of expired opioid antagonists

Impact

The passage of SB503 would amend existing Montana statutes to ensure that schools can maintain a stock supply of opioid antagonists, such as naloxone, and effectively train staff for their administration. This means more individuals and institutions would be able to respond swiftly to opioid overdoses, potentially saving lives where immediate medical assistance might not be available. Additionally, it ensures that those administering these medications would not face legal action unless they acted with gross negligence.

Summary

Senate Bill 503 (SB503) aims to expand the accessibility and use of opioid antagonists, specifically allowing the use of expired opioid antagonists without the fear of legal repercussions. The bill provides partial immunity from civil or criminal liability for medical practitioners, pharmacists, school employees, and eligible recipients who administer or distribute these medications during opioid overdose emergencies. The intent is to save lives by promoting broader use and distribution of these lifesaving drugs.

Sentiment

General sentiment towards SB503 appears to be supportive, with legislators and advocacy groups recognizing the importance of increasing access to opioid antagonists in the face of the ongoing opioid crisis. Proponents argue that the bill provides essential legal protections that encourage more people to carry and use these medications. However, there may be concerns regarding the implications of allowing the use of expired medications, questioning their effectiveness and safety in overdose situations.

Contention

One potential point of contention lies in the provision that allows for expired opioid antagonists to be used, as this raises questions about efficacy and public safety. Some opposition may arise from those worried that this allowance could promote negligence in medication practices. Additionally, while the immunity provisions are intended to foster a supportive environment for life-saving interventions, there may be concerns about the ethical implications of using expired substances, leading to debates about how best to balance these interests.

Companion Bills

No companion bills found.

Previously Filed As

MT HB2697

Expired opioid antagonists; use

MT HB310

Relating To Opioid Antagonists.

MT HB310

Relating To Opioid Antagonists.

MT SB2855

Relating To Opioid Antagonists.

MT HB1910

LIBRARIES-OPIOID ANTAGONISTS

MT HB547

AN ACT relating to opioid antagonists.

MT HB1399

Relating To Opioid Antagonists.

MT HB1399

Relating To Opioid Antagonists.

MT HB431

AN ACT relating to opioid antagonists.

MT HB1293

Drug Overdose Education & Opioid Antagonists in Schools

Similar Bills

HI HB310

Relating To Opioid Antagonists.

HI HB310

Relating To Opioid Antagonists.

AZ HB2697

Expired opioid antagonists; use

TX HB4783

Relating to a report on governmental opioid antagonist programs to reverse and prevent opioid overdoses.

TX HB1103

Relating to measures to prevent and respond to opioid-related drug overdoses, including policies and training regarding the use of opioid antagonists, at student residences on campuses of public institutions of higher education; providing immunity.

TX SB556

Relating to measures to prevent and respond to opioid-related drug overdoses, including policies and training regarding the use of opioid antagonists, at student residences on campuses of public institutions of higher education; providing immunity.

MI SB0401

Health: pharmaceuticals; co-prescribing of naloxone with opioid drugs; require. Amends sec. 17744b of 1978 PA 368 (MCL 333.17744b).

IL HB3326

METRA-NALOXONE REQUIREMENT